Motorized optical imaging of prostate cancer
A system, method, and storage device storing computer executable instructions for use in tissue analysis and therapy. A motorized optical probe for illuminating tissue generates light fluorescence and/or diffuse reflectance signals corresponding to the illuminated tissue. One or more ultrasound, CT and MRI imaging guidance systems identify the position of the optical probes relative to the tissue. An imaging system generates a three-dimensional image of the tissue based on the generated light signals and the identified position of the optical probe.
1. A system for evaluating a segment of tissue in a body comprising:
a needle having at least one fiber optic cable adapted to transmit light from a light source to illuminate a first location along the segment of tissue and to transmit spectra emanating from the first location;
a system console comprising
a fluorometer configured to evaluate the spectra and generate signals of selected data of the spectra, and
a module executing a classification algorithm wherein the classification algorithm classifies tissue at the first location based only on the generated signals to generate a classification, wherein the classification indicates tissue condition and is provided real-time to a display by correlating the first location to a three-dimensional image of the tissue and generating a three-dimensional optical spectroscopic image showing the first location and classification in relation to the three-dimensional image while the needle is positioned to illuminate the first location; and
an autoneedle advancement mechanism configured to automatically advance the needle in a preselected increment after the classification of tissue at the first location has been provided to the display, wherein the preselected increment advances the needle to allow illumination at a next location along the segment of tissue.
2. A system as in claim 1 , wherein the autoneedle advancement mechanism automatically advances the needle according to a preset number of preselected increments, wherein each preselected increment has a corresponding location along the segment of tissue and classification of tissue of the corresponding location.
3. A system as in claim 2 , wherein the autoneedle advancement mechanism automatically stops advancing the needle after the preset number of increments.
4. A system as in claim 2 , wherein the needle includes a collection space for biopsy and the preset number of preselected increments equals a length of the collection space.
5. A system as in claim 2 , wherein the preset number of preselected increments equals 18.
6. A system as in claim 1 , wherein the preselected increment is 1 mm.
7. A system as in claim 1 , wherein the autoneedle advancement mechanism comprises a stepper motor.
8. A system as in claim 1 , wherein the needle includes a collection space for biopsy and wherein the needle includes an outer cannula which is advanceable over the collection space to shear and collect the tissue creating a biopsy.
9. A system as in claim 8 , wherein advancement of the outer cannula over the collection space while the needle is positioned to illuminate the first location biopsies tissue at the first location and not tissue at the next location.
10. A system as in claim 8 , wherein the outer cannula is advanceable of over the collection space by at least one of a motor and a spring.
11. A system as in claim 8 , wherein advancement of the outer cannula of over the collection space stops automatic advancement of the needle.
12. A system as in claim 1 , wherein the classification comprises benign, malignant, abnormal, cancer, disease or calcified.
13. A system as in claim 1 , wherein the tissue comprises prostate tissue.
14. A system as in claim 1 , wherein the spectra comprise auto-fluorescence spectra.
15. A system as in claim 14 , wherein the signals of selected data of the auto-fluorescence spectra comprise isolated fluorescence of at least one endogenous fluorophore.
16. A system as in claim 15 , wherein the at least one endogenous fluorophore comprises NADH, tryptophan, and/or collagen.
17. A system as in claim 1 , wherein the spectra comprise diffuse reflectance spectra.
18. A system as in claim 1 , wherein the system console includes a master control unit module which has its own microcontroller and communicates with and controls the light source, needle, fluorometer and module executing the classification algorithm so as to synchronize real-time display of the tissue condition with the autoneedle advancement mechanism.
19. A system as in claim 1 , wherein the light source comprises a 280-290 nm light source, a 340 nm light source for generating auto-fluorescence spectra and a 450-700 nm light source for generating diffuse reflectance spectra.
20. A system as in claim 1 , further comprising an ultrasound imaging system comprising an ultrasound probe configured for generating ultrasound signals indicative of the position of the needle relative to the body and an ultrasound system adapted for evaluating the ultrasound signals and providing display signals illustrating the position of the needle relative to the body.
21. A method for evaluating a segment of tissue in a body comprising:
positioning a needle into the tissue, wherein the needle has a handle disposed outside of the body at a predetermined distance from the tissue;
holding the handle at the predetermined distance while light transmitted is from the needle to illuminate a first location along the segment of tissue and spectra emanating from the first location in response to the light is collected by the needle, wherein the spectra is evaluated by a fluorometer which generates signals of selected data of the spectra; and
generating and observing a classification of the tissue at the first location on a display while the needle is in position in the tissue by correlating the first location to a three-dimensional image of the tissue, wherein the classification indicates tissue condition and is determined by a classification algorithm based only on the signals of selected data of the spectra provided by the fluorometer, and wherein a three-dimensional optical spectroscopic image showing the first location and classification in relation to the three-dimensional image of the tissue.
22. A method as in claim 21 , further comprising advancing an outer cannula over a collection space in the needle while the needle is positioned to illuminate the first location, wherein advancing the outer cannula shears and collects tissue from the first location for biopsy.
23. A method as in claim 22 , wherein the advancing step is achieved by actuating a mechanism in the handle.
24. A method as in claim 23 , wherein the mechanism comprises a motor or spring.
25. A method as in claim 23 , wherein actuating the mechanism in the handle stops automatic advancement of the needle.
26. A method as in claim 23 , wherein the classification comprises benign, malignant, abnormal, cancer, disease or calcified.
27. A method as in claim 23 , wherein the tissue comprises prostate tissue.
28. A method as in claim 21 , further comprising:
maintaining position of the handle at the predetermined distance while the needle automatically advances in a preselected increment by an autoneedle advancement mechanism so that the needle is positioned to allow light transmitted from the needle to illuminate a next location along the segment of tissue and spectra emanating from the next location in response to the light of the next location is collected by the needle.
29. A method as in claim 28 , further comprising maintaining position of the handle at the predetermined distance while the autoneedle advancement mechanism advances the needle a preset number of preselected increments.
30. A method as in claim 29 , wherein the preset number of preselected increments equals 18.
31. A method as in claim 28 , further comprising maintaining position of the handle at the predetermined distance while the needle automatically advances a maximum present number of preselected increments while observing real-time classification of the tissue on the display at each location along the segment of tissue.
32. A method as in claim 28 , further comprising:
observing a next classification of the tissue at the next location on the display while the needle is in position in the tissue, wherein the next classification indicates tissue condition and is determined by the classification algorithm based on signals of selected data of the spectra emanating from the next location provided by the fluorometer.
33. A method as in claim 28 , further comprising advancing an outer cannula over a collection space in the needle while the needle is positioned to illuminate the first location, wherein advancing the outer cannula shears and collects tissue from the first location for biopsy.
34. A method as in claim 33 , wherein the advancing step is achieved by actuating a mechanism in the handle and wherein actuating the mechanism in the handle stops automatic advancement of the needle.